SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment

By Jan 31, 2020, the National Medical Products Administration urgently approved six nucleic acid detection kits, and post-market evaluation with a multicentre clinical trial was completed by professional institutions by the end of February, 2020. NAAT laboratories have been in development across Chi...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2022-04, Vol.399 (10336), p.1690-1691
Main Authors: Han, Xiaoxu, Li, Jinming, Chen, Yu, Li, Yan, Xu, Yingchun, Ying, Binwu, Shang, Hong
Format: Article
Language:English
Subjects:
Acids
China - epidemiology
Coronaviruses
Correspondence
COVID-19
Disease control
Epidemics
Fever
Hepatitis
Hepatitis B
Hepatitis C
HIV
Hospitals
Human immunodeficiency virus
Humans
Infectious diseases
Laboratories
Medical equipment
Nucleic Acid Amplification Techniques
Nucleic Acids
Optimization
Pandemics
Population
Public health
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Testing laboratories
Viral diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c495t-9086d0f292566c9fda079370dc4e32747c27d017e7ebbdf080261685ea414eac3
cites cdi_FETCH-LOGICAL-c495t-9086d0f292566c9fda079370dc4e32747c27d017e7ebbdf080261685ea414eac3
container_end_page 1691
container_issue 10336
container_start_page 1690
container_title The Lancet (British edition)
container_volume 399
creator Han, Xiaoxu
Li, Jinming
Chen, Yu
Li, Yan
Xu, Yingchun
Ying, Binwu
Shang, Hong
description By Jan 31, 2020, the National Medical Products Administration urgently approved six nucleic acid detection kits, and post-market evaluation with a multicentre clinical trial was completed by professional institutions by the end of February, 2020. NAAT laboratories have been in development across China for decades; thousands of NAAT laboratories for detecting infectious agents such as hepatitis B virus, hepatitis C virus, and HIV are established in large hospitals, blood centres, and in the Chinese Center for Disease Control and Prevention. To improve the efficiency of mass screening, China has adopted the sample pooling strategy in three patterns (five, ten, or 20 pooled samples) on the basis of different epidemic periods.4,5 With the optimisation of sample pooling methodology and development of an electronic information system, this sample pooling strategy ensures both high sensitivity and efficiency.
doi_str_mv 10.1016/S0140-6736(22)00577-3
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8989390</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673622005773</els_id><sourcerecordid>2649256786</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-9086d0f292566c9fda079370dc4e32747c27d017e7ebbdf080261685ea414eac3</originalsourceid><addsrcrecordid>eNqFkUtvFDEQhC0EIkvgJ4AscSAcDG2PH-MLKBpekYIisRBxs7weT-Iway_2TKT8e7zZsAIunHzw19VVXQg9pfCKApWvl0A5EKkaecTYSwChFGnuoQXlihPB1ff7aLFHDtCjUq4AgEsQD9FBIxqtWgEL9Hl5_GVJunROGI6zG31w2LrQ48mXKcQLHAruLkO0Lwr-4W_wJoyjzTgNuDs7P3lHqMYuxcmGuPZxeoweDHYs_snde4i-fXj_tftETs8-nnTHp8RxLSaioZU9DEwzIaXTQ29B6UZB77hvmOLKMdUDVV751aofoAUmqWyFt5xyb11ziN7sdDfzau17V1dnO5pNDmubb0yywfz9E8OluUjXptWtbjRUgaM7gZx-zjWqWYfifM0WfZqLYZJvzalWVvT5P-hVmnOs8SpV_QumtK6U2FEup1KyH_ZmKJhtYea2MLNtwzBmbgszTZ179meS_dTvhirwdgf4es_r4LMpLvjofB-yd5PpU_jPil_POqLn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2656652799</pqid></control><display><type>article</type><title>SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Han, Xiaoxu ; Li, Jinming ; Chen, Yu ; Li, Yan ; Xu, Yingchun ; Ying, Binwu ; Shang, Hong</creator><creatorcontrib>Han, Xiaoxu ; Li, Jinming ; Chen, Yu ; Li, Yan ; Xu, Yingchun ; Ying, Binwu ; Shang, Hong</creatorcontrib><description>By Jan 31, 2020, the National Medical Products Administration urgently approved six nucleic acid detection kits, and post-market evaluation with a multicentre clinical trial was completed by professional institutions by the end of February, 2020. NAAT laboratories have been in development across China for decades; thousands of NAAT laboratories for detecting infectious agents such as hepatitis B virus, hepatitis C virus, and HIV are established in large hospitals, blood centres, and in the Chinese Center for Disease Control and Prevention. To improve the efficiency of mass screening, China has adopted the sample pooling strategy in three patterns (five, ten, or 20 pooled samples) on the basis of different epidemic periods.4,5 With the optimisation of sample pooling methodology and development of an electronic information system, this sample pooling strategy ensures both high sensitivity and efficiency.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(22)00577-3</identifier><identifier>PMID: 35397850</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acids ; China - epidemiology ; Coronaviruses ; Correspondence ; COVID-19 ; Disease control ; Epidemics ; Fever ; Hepatitis ; Hepatitis B ; Hepatitis C ; HIV ; Hospitals ; Human immunodeficiency virus ; Humans ; Infectious diseases ; Laboratories ; Medical equipment ; Nucleic Acid Amplification Techniques ; Nucleic Acids ; Optimization ; Pandemics ; Population ; Public health ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Testing laboratories ; Viral diseases</subject><ispartof>The Lancet (British edition), 2022-04, Vol.399 (10336), p.1690-1691</ispartof><rights>2022 Elsevier Ltd</rights><rights>2022. Elsevier Ltd</rights><rights>2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-9086d0f292566c9fda079370dc4e32747c27d017e7ebbdf080261685ea414eac3</citedby><cites>FETCH-LOGICAL-c495t-9086d0f292566c9fda079370dc4e32747c27d017e7ebbdf080261685ea414eac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35397850$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Xiaoxu</creatorcontrib><creatorcontrib>Li, Jinming</creatorcontrib><creatorcontrib>Chen, Yu</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Xu, Yingchun</creatorcontrib><creatorcontrib>Ying, Binwu</creatorcontrib><creatorcontrib>Shang, Hong</creatorcontrib><title>SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>By Jan 31, 2020, the National Medical Products Administration urgently approved six nucleic acid detection kits, and post-market evaluation with a multicentre clinical trial was completed by professional institutions by the end of February, 2020. NAAT laboratories have been in development across China for decades; thousands of NAAT laboratories for detecting infectious agents such as hepatitis B virus, hepatitis C virus, and HIV are established in large hospitals, blood centres, and in the Chinese Center for Disease Control and Prevention. To improve the efficiency of mass screening, China has adopted the sample pooling strategy in three patterns (five, ten, or 20 pooled samples) on the basis of different epidemic periods.4,5 With the optimisation of sample pooling methodology and development of an electronic information system, this sample pooling strategy ensures both high sensitivity and efficiency.</description><subject>Acids</subject><subject>China - epidemiology</subject><subject>Coronaviruses</subject><subject>Correspondence</subject><subject>COVID-19</subject><subject>Disease control</subject><subject>Epidemics</subject><subject>Fever</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Laboratories</subject><subject>Medical equipment</subject><subject>Nucleic Acid Amplification Techniques</subject><subject>Nucleic Acids</subject><subject>Optimization</subject><subject>Pandemics</subject><subject>Population</subject><subject>Public health</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Testing laboratories</subject><subject>Viral diseases</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkUtvFDEQhC0EIkvgJ4AscSAcDG2PH-MLKBpekYIisRBxs7weT-Iway_2TKT8e7zZsAIunHzw19VVXQg9pfCKApWvl0A5EKkaecTYSwChFGnuoQXlihPB1ff7aLFHDtCjUq4AgEsQD9FBIxqtWgEL9Hl5_GVJunROGI6zG31w2LrQ48mXKcQLHAruLkO0Lwr-4W_wJoyjzTgNuDs7P3lHqMYuxcmGuPZxeoweDHYs_snde4i-fXj_tftETs8-nnTHp8RxLSaioZU9DEwzIaXTQ29B6UZB77hvmOLKMdUDVV751aofoAUmqWyFt5xyb11ziN7sdDfzau17V1dnO5pNDmubb0yywfz9E8OluUjXptWtbjRUgaM7gZx-zjWqWYfifM0WfZqLYZJvzalWVvT5P-hVmnOs8SpV_QumtK6U2FEup1KyH_ZmKJhtYea2MLNtwzBmbgszTZ179meS_dTvhirwdgf4es_r4LMpLvjofB-yd5PpU_jPil_POqLn</recordid><startdate>20220430</startdate><enddate>20220430</enddate><creator>Han, Xiaoxu</creator><creator>Li, Jinming</creator><creator>Chen, Yu</creator><creator>Li, Yan</creator><creator>Xu, Yingchun</creator><creator>Ying, Binwu</creator><creator>Shang, Hong</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220430</creationdate><title>SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment</title><author>Han, Xiaoxu ; Li, Jinming ; Chen, Yu ; Li, Yan ; Xu, Yingchun ; Ying, Binwu ; Shang, Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-9086d0f292566c9fda079370dc4e32747c27d017e7ebbdf080261685ea414eac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acids</topic><topic>China - epidemiology</topic><topic>Coronaviruses</topic><topic>Correspondence</topic><topic>COVID-19</topic><topic>Disease control</topic><topic>Epidemics</topic><topic>Fever</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Laboratories</topic><topic>Medical equipment</topic><topic>Nucleic Acid Amplification Techniques</topic><topic>Nucleic Acids</topic><topic>Optimization</topic><topic>Pandemics</topic><topic>Population</topic><topic>Public health</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Testing laboratories</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Xiaoxu</creatorcontrib><creatorcontrib>Li, Jinming</creatorcontrib><creatorcontrib>Chen, Yu</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Xu, Yingchun</creatorcontrib><creatorcontrib>Ying, Binwu</creatorcontrib><creatorcontrib>Shang, Hong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Xiaoxu</au><au>Li, Jinming</au><au>Chen, Yu</au><au>Li, Yan</au><au>Xu, Yingchun</au><au>Ying, Binwu</au><au>Shang, Hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2022-04-30</date><risdate>2022</risdate><volume>399</volume><issue>10336</issue><spage>1690</spage><epage>1691</epage><pages>1690-1691</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>By Jan 31, 2020, the National Medical Products Administration urgently approved six nucleic acid detection kits, and post-market evaluation with a multicentre clinical trial was completed by professional institutions by the end of February, 2020. NAAT laboratories have been in development across China for decades; thousands of NAAT laboratories for detecting infectious agents such as hepatitis B virus, hepatitis C virus, and HIV are established in large hospitals, blood centres, and in the Chinese Center for Disease Control and Prevention. To improve the efficiency of mass screening, China has adopted the sample pooling strategy in three patterns (five, ten, or 20 pooled samples) on the basis of different epidemic periods.4,5 With the optimisation of sample pooling methodology and development of an electronic information system, this sample pooling strategy ensures both high sensitivity and efficiency.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>35397850</pmid><doi>10.1016/S0140-6736(22)00577-3</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2022-04, Vol.399 (10336), p.1690-1691
issn 0140-6736
1474-547X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8989390
source ScienceDirect Freedom Collection 2022-2024
subjects Acids
China - epidemiology
Coronaviruses
Correspondence
COVID-19
Disease control
Epidemics
Fever
Hepatitis
Hepatitis B
Hepatitis C
HIV
Hospitals
Human immunodeficiency virus
Humans
Infectious diseases
Laboratories
Medical equipment
Nucleic Acid Amplification Techniques
Nucleic Acids
Optimization
Pandemics
Population
Public health
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Testing laboratories
Viral diseases
title SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A28%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SARS-CoV-2%20nucleic%20acid%20testing%20is%20China's%20key%20pillar%20of%20COVID-19%20containment&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Han,%20Xiaoxu&rft.date=2022-04-30&rft.volume=399&rft.issue=10336&rft.spage=1690&rft.epage=1691&rft.pages=1690-1691&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(22)00577-3&rft_dat=%3Cproquest_pubme%3E2649256786%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c495t-9086d0f292566c9fda079370dc4e32747c27d017e7ebbdf080261685ea414eac3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2656652799&rft_id=info:pmid/35397850&rfr_iscdi=true